137 related articles for article (PubMed ID: 8473288)
1. Binding of lipoprotein lipase to heparin. Identification of five critical residues in two distinct segments of the amino-terminal domain.
Hata A; Ridinger DN; Sutherland S; Emi M; Shuhua Z; Myers RL; Ren K; Cheng T; Inoue I; Wilson DE
J Biol Chem; 1993 Apr; 268(12):8447-57. PubMed ID: 8473288
[TBL] [Abstract][Full Text] [Related]
2. Binding of hepatic lipase to heparin. Identification of specific heparin-binding residues in two distinct positive charge clusters.
Sendak RA; Berryman DE; Gellman G; Melford K; Bensadoun A
J Lipid Res; 2000 Feb; 41(2):260-8. PubMed ID: 10681410
[TBL] [Abstract][Full Text] [Related]
3. Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390-393, and 439-448) and identification of residues affecting heparin binding of human lipoprotein lipase.
Ma Y; Henderson HE; Liu MS; Zhang H; Forsythe IJ; Clarke-Lewis I; Hayden MR; Brunzell JD
J Lipid Res; 1994 Nov; 35(11):2049-59. PubMed ID: 7868983
[TBL] [Abstract][Full Text] [Related]
4. Identification of the epitope of a monoclonal antibody that inhibits heparin binding of lipoprotein lipase: new evidence for a carboxyl-terminal heparin-binding domain.
Sendak RA; Melford K; Kao A; Bensadoun A
J Lipid Res; 1998 Mar; 39(3):633-46. PubMed ID: 9548595
[TBL] [Abstract][Full Text] [Related]
5. Site-directed mutagenesis of a putative heparin binding domain of avian lipoprotein lipase.
Berryman DE; Bensadoun A
J Biol Chem; 1993 Feb; 268(5):3272-6. PubMed ID: 8429005
[TBL] [Abstract][Full Text] [Related]
6. Identification of a heparin-binding domain in the distal carboxyl-terminal region of lipoprotein lipase by site-directed mutagenesis.
Sendak RA; Bensadoun A
J Lipid Res; 1998 Jun; 39(6):1310-5. PubMed ID: 9643364
[TBL] [Abstract][Full Text] [Related]
7. Subdomain chimeras of hepatic lipase and lipoprotein lipase. Localization of heparin and cofactor binding.
Hill JS; Yang D; Nikazy J; Curtiss LK; Sparrow JT; Wong H
J Biol Chem; 1998 Nov; 273(47):30979-84. PubMed ID: 9812994
[TBL] [Abstract][Full Text] [Related]
8. Effects of gene mutations in lipoprotein and hepatic lipases as interpreted by a molecular model of the pancreatic triglyceride lipase.
Derewenda ZS; Cambillau C
J Biol Chem; 1991 Dec; 266(34):23112-9. PubMed ID: 1744109
[TBL] [Abstract][Full Text] [Related]
9. Segments in the C-terminal folding domain of lipoprotein lipase important for binding to the low density lipoprotein receptor-related protein and to heparan sulfate proteoglycans.
Nielsen MS; Brejning J; García R; Zhang H; Hayden MR; Vilaró S; Gliemann J
J Biol Chem; 1997 Feb; 272(9):5821-7. PubMed ID: 9038197
[TBL] [Abstract][Full Text] [Related]
10. Chimeras of hepatic lipase and lipoprotein lipase. Domain localization of enzyme-specific properties.
Davis RC; Wong H; Nikazy J; Wang K; Han Q; Schotz MC
J Biol Chem; 1992 Oct; 267(30):21499-504. PubMed ID: 1400461
[TBL] [Abstract][Full Text] [Related]
11. Analysis of heparin-binding sites in human lipoprotein lipase using synthetic peptides.
Beg OU; Uddin M; Siddiqi AR
J Protein Chem; 1998 Nov; 17(8):807-15. PubMed ID: 9988527
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional roles of highly conserved serines in human lipoprotein lipase. Evidence that serine 132 is essential for enzyme catalysis.
Faustinella F; Smith LC; Semenkovich CF; Chan L
J Biol Chem; 1991 May; 266(15):9481-5. PubMed ID: 1903387
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein lipase from rainbow trout differs in several respects from the enzyme in mammals.
Lindberg A; Olivecrona G
Gene; 2002 Jun; 292(1-2):213-23. PubMed ID: 12119116
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein lipase domain function.
Wong H; Davis RC; Thuren T; Goers JW; Nikazy J; Waite M; Schotz MC
J Biol Chem; 1994 Apr; 269(14):10319-23. PubMed ID: 8144612
[TBL] [Abstract][Full Text] [Related]
15. Interaction of lipoprotein lipase with heparin.
Oka K; Wang-Iverson P; Paterniti JR; Brown WV
Ann N Y Acad Sci; 1989; 556():173-80. PubMed ID: 2735657
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling of the dimeric structure of human lipoprotein lipase and functional studies of the carboxyl-terminal domain.
Kobayashi Y; Nakajima T; Inoue I
Eur J Biochem; 2002 Sep; 269(18):4701-10. PubMed ID: 12230584
[TBL] [Abstract][Full Text] [Related]
17. Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics.
Lookene A; Chevreuil O; Ostergaard P; Olivecrona G
Biochemistry; 1996 Sep; 35(37):12155-63. PubMed ID: 8810923
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein lipaseBethesda: a single amino acid substitution (Ala-176----Thr) leads to abnormal heparin binding and loss of enzymic activity.
Beg OU; Meng MS; Skarlatos SI; Previato L; Brunzell JD; Brewer HB; Fojo SS
Proc Natl Acad Sci U S A; 1990 May; 87(9):3474-8. PubMed ID: 2110364
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the carboxy-terminal domain of lipoprotein lipase to interaction with heparin and lipoproteins.
Lookene A; Nielsen MS; Gliemann J; Olivecrona G
Biochem Biophys Res Commun; 2000 Apr; 271(1):15-21. PubMed ID: 10777674
[TBL] [Abstract][Full Text] [Related]
20. Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues.
Lutz EP; Merkel M; Kako Y; Melford K; Radner H; Breslow JL; Bensadoun A; Goldberg IJ
J Clin Invest; 2001 May; 107(9):1183-92. PubMed ID: 11342582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
